This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new federal report suggests that U.S. autism rates are rising modestly, an increase that health researchers said reflected expanded diagnostic tools and access to care, among other factors. But health secretary Robert F. Kennedy Jr. instead has pointed to the data as evidence of a growing crisis. The Centers for Disease Control and Prevention report says that 3.2% of kids surveyed in 2022 have autism spectrum disorder, a slight uptick from the 2.8% of kids surveyed in 2020 for the previous rep
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced it will be phasing out the current requirements for animal testing in the development of monoclonal antibody therapies and other drugs, replacing them with more effective, human-relevant methods. According to the FDA, the animal testing requirement will be reduced, refined, or potentially replaced using a range of approaches, including AI-based computational models of toxicity and cell lines and organoid toxicity testing in
A meeting of vaccine advisers long targeted by Health Secretary Robert F. Kennedy Jr. unfolded Tuesday seemingly without fireworks or interference, although the new administration’s imprint could be seen from the start, when staff for the Centers for Disease Control and Prevention, gutted by layoffs, struggled to get a livestream running.
Brian Thompson’s murder has raised questions about the cost of U.S. healthcare, embroiling insurers, drugmakers and PBMs in a battle for the future of the industry.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
New recommendations issued by the EMA and the Heads of Medicines Agencies (HMA), through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) , aim to address supply chain vulnerabilities for radiopharmaceutical medicines. Occasional shortages of radiopharmaceuticals have emerged in different EU Member States, due to disparity between manufacturing capacity and demand, according to the EMA.
This collaboration primarily aims to concentrate on expediting production of the recessive dystrophic epidermolysis bullosa (RDEB) therapy CORDStrom. An independent technology and innovation organisation, CGT Catapult focuses on progressing the cell and gene therapy industry. It was established by and operates in collaboration with Innovate UK. INmune Bios therapies focus on harnessing the innate immune system for treating a variety of diseases, including prostate cancer, Alzheimers and RDEB.
This collaboration primarily aims to concentrate on expediting production of the recessive dystrophic epidermolysis bullosa (RDEB) therapy CORDStrom. An independent technology and innovation organisation, CGT Catapult focuses on progressing the cell and gene therapy industry. It was established by and operates in collaboration with Innovate UK. INmune Bios therapies focus on harnessing the innate immune system for treating a variety of diseases, including prostate cancer, Alzheimers and RDEB.
Creating engaging content can have many different goals. For some businesses, it’s to attract new customers, while for others, it’s to spread awareness about their brand’s values and goals. Regardless of the goal, one consistent effect of high-quality content is improved brand loyalty. In this guide, we will delve deeper into the topic of building brand loyalty through strategic content creation and discuss how your business can leverage this approach to drive repeat sales and
The Tamil Nadu Drugs Control Department has seized hair oil products worth approximately 2.82 lakh from Garuda Herbals following a complaint filed by Humane World for Animals India (formerly Humane Society International India). The seizure was carried out under the provisions of the Drugs and Cosmetics Act, 1940, after an inspection at the manufacturers premises in Tamil Nadu.
Why Technology Is the Key to CSRD Compliance Pranil Tue, 04/15/2025 - 19:09 Picture this: A multinational company struggling to align its complex supply chain data with the stringent CSRD requirements. The challenge of complicated metrics and manual processes is a familiar scene. But with the right tools, this narrative can change dramatically. Could your business leverage the CSRD challenge as a strategic advantage?
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
"Breaking the Bank on Generic Drug Testing? Did you know that Analytical Method Development and Validation can account for up to 70% of the total cost of generic drug testing? At DrugPatentWatch, we've cracked the code on cost-effective approaches to speed up your generic drug testing process without sacrificing quality.
Why competitive intelligence professionals are combining AI and human insight for more reliable decision-making The rapid advancement of AI in competitive intelligence (CI) has introduced new tools and capabilities for data collection and analysis. But even as adoption increases, one element remains essential: human-sourced intelligence. As organizations face more complex markets and faster shifts in competitive dynamics, combining AI-powered tools with primary research is emerging as a best pra
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether other drugs like it would similarly struggle in testing.
Competitive intelligence (CI) is no longer confined to sales decks and strategic planning meetings. The most competitive companies are embedding CI across the entire businessfrom product development and supply chain to pricing and talent acquisition. By enabling faster, evidence-based decisions, CI is helping organizations reduce risk, anticipate disruption, and outmaneuver the competition.
In todays fast-moving pharmaceutical marketplace, insight is everything. Whether you're building trust with customers, launching new products, or guiding internal teams, understanding the economic forces that shape drug distribution, reimbursement, and pricing is essential. At Drug Channels Institute (DCI) , we know how critical this knowledge isand how hard it can be to find credible, up-to-date training that fits into a busy professionals schedule.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
HHS bypassed normal procedures as it laid off thousands of employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
Explore how the EU healthcare industry is leveraging data, digitalisation, and artificial intelligence to revolutionise medicines regulation. Learn about the advancements and benefits of this new era.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential. The research, published in Proceedings of the National Academy of Sciences, highlights the new drug's potential as a treatment option for conditions like schizophrenia, where psychedelics are not prescribed for safety reasons.
"BREAKING: The $100 Billion Question - Can Biosimilars Disrupt the Status Quo in Biologic Drug Reimbursement Models? As the biologic market continues to grow, the impact of biosimilars on reimbursement models is becoming increasingly clear. With the average price of a biologic medication reaching upwards of $100,000 per year, the stakes are high.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
In the Phase III ODYSSEY-HCM trial, patients treated with Camzyos for symptomatic non-obstructive hypertrophic cardiomyopathy did not show significant improvements based on Kansas City Cardiomyopathy Questionnaire Clinical Summary Scores and peak oxygen consumption.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
361 
Let's personalize your content